电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant IL23A (Tildrakizumab Biosimilar) 抗体

This anti-IL23A (Tildrakizumab Biosimilar) antibody is a Human 单克隆 antibody detecting IL23A (Tildrakizumab Biosimilar) in ELISA, BLI, FACS, Func 和 SPR. Suitable for 人.
产品编号 ABIN7675773
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant IL23A (Tildrakizumab Biosimilar) 抗体 (ABIN7675773)

抗原

IL23A (Tildrakizumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 1
  • 1
Human

克隆类型

  • 1
  • 1
单克隆

标记

  • 2
This IL23A (Tildrakizumab Biosimilar) antibody is un-conjugated

应用范围

ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    原理

    Anti-IL-23a Reference Antibody (tildrakizumab)

    序列

    QVQLVQSGAE VKKPGASVKV SCKASGYIFI TYWMTWVRQA PGQGLEWMGQ IFPASGSADY NEKFEGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARGG GGFAYWGQGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIQMTQSPSS LSASVGDRVT ITCRTSENIY SYLAWYQQKP GKAPKLLIYN AKTLAEGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQH HYGIPFTFGQ GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC

    产品特性

    Anti-IL-23a Reference Antibody (tildrakizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    纯度

    >95 %

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    说明

    Therapeutic Agents by Target and Mechanism: IL-23p19 inhibitors

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    1 mg/mL

    缓冲液

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    储存条件

    4 °C,-80 °C

    储存方法

    +4°C,-80°C
  • 抗原

    IL23A (Tildrakizumab Biosimilar)

    别名

    IL-23a (Tildrakizumab Biosimilar)

    物质类

    Biosimilar

    分子量

    145.5 kDa

    UniProt

    Q9NPF7
You are here: